Penelope A. Morel

7.1k total citations · 1 hit paper
116 papers, 5.5k citations indexed

About

Penelope A. Morel is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Penelope A. Morel has authored 116 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Immunology, 23 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Molecular Biology. Recurrent topics in Penelope A. Morel's work include Immune Cell Function and Interaction (47 papers), T-cell and B-cell Immunology (44 papers) and Immunotherapy and Immune Responses (31 papers). Penelope A. Morel is often cited by papers focused on Immune Cell Function and Interaction (47 papers), T-cell and B-cell Immunology (44 papers) and Immunotherapy and Immune Responses (31 papers). Penelope A. Morel collaborates with scholars based in United States, France and China. Penelope A. Morel's co-authors include Eric T. Ahrens, Maryam Feili‐Hariri, Hongyan Xu, Michael S. Turner, Rafael R. Flores, Timothy B. Oriss, Dewayne Falkner, Larry Kane, John A. Todd and Janice S. Dorman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Penelope A. Morel

115 papers receiving 5.4k citations

Hit Papers

In vivo imaging platform for tracking immunotherapeutic c... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers

Penelope A. Morel
Peter D. Katsikis United States
Tri Giang Phan Australia
John W. Smith United States
Douglas H. Thamm United States
Richard A. Miller United States
Raymond J. Paxton United States
Christine T. N. Pham United States
Peter D. Katsikis United States
Penelope A. Morel
Citations per year, relative to Penelope A. Morel Penelope A. Morel (= 1×) peers Peter D. Katsikis

Countries citing papers authored by Penelope A. Morel

Since Specialization
Citations

This map shows the geographic impact of Penelope A. Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penelope A. Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penelope A. Morel more than expected).

Fields of papers citing papers by Penelope A. Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penelope A. Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penelope A. Morel. The network helps show where Penelope A. Morel may publish in the future.

Co-authorship network of co-authors of Penelope A. Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Penelope A. Morel. A scholar is included among the top collaborators of Penelope A. Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penelope A. Morel. Penelope A. Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Morel, Penelope A., et al.. (2023). Alternatively Spliced Variants of Murine CD247 Influence T Cell Development and Activation, Revealing the Importance of the CD3ζ C-Terminal Region. The Journal of Immunology. 212(4). 541–550. 4 indexed citations
3.
Wu, Shaoxian, Hao Huang, Runzi Sun, et al.. (2023). Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment. Cancer Research Communications. 3(8). 1460–1472. 8 indexed citations
4.
Jenner, Adrianne L., Rosemary A. Aogo, Xiaoyan Deng, et al.. (2021). COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes. PLoS Pathogens. 17(7). e1009753–e1009753. 50 indexed citations
5.
McTiernan, Charles F., Penelope A. Morel, Leslie T. Cooper, et al.. (2017). Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study. Journal of Cardiac Failure. 24(1). 33–42. 10 indexed citations
6.
Hawse, William F., Robert P. Sheehan, Nataša Miškov-Živanov, et al.. (2015). Cutting Edge: Differential Regulation of PTEN by TCR, Akt, and FoxO1 Controls CD4+ T Cell Fate Decisions. The Journal of Immunology. 194(10). 4615–4619. 38 indexed citations
7.
Turner, Michael S., Larry Kane, & Penelope A. Morel. (2009). Dominant Role of Antigen Dose in CD4+Foxp3+ Regulatory T Cell Induction and Expansion. The Journal of Immunology. 183(8). 4895–4903. 147 indexed citations
8.
Flores, Rafael R., et al.. (2007). IFN-γ Negatively Regulates CpG-Induced IL-10 in Bone Marrow-Derived Dendritic Cells. The Journal of Immunology. 178(1). 211–218. 25 indexed citations
9.
Zhao, Wei, et al.. (2006). FcγRIIa, Not FcγRIIb, Is Constitutively and Functionally Expressed on Skin-Derived Human Mast Cells. The Journal of Immunology. 177(1). 694–701. 100 indexed citations
10.
Feili‐Hariri, Maryam, Rafael R. Flores, A. Cecilia Vasquez, & Penelope A. Morel. (2006). Dendritic Cell Immunotherapy for Autoimmune Diabetes. Immunologic Research. 36(1-3). 167–174. 12 indexed citations
11.
Chen, Xiao‐Ping, Dewayne Falkner, & Penelope A. Morel. (2005). Impaired IL‐4 production by CD8+ T cells in NOD mice is related to a defect of c‐Maf binding to the IL‐4 promoter. European Journal of Immunology. 35(5). 1408–1417. 11 indexed citations
12.
Ahrens, Eric T., Rafael R. Flores, Hongyan Xu, & Penelope A. Morel. (2005). In vivo imaging platform for tracking immunotherapeutic cells. Nature Biotechnology. 23(8). 983–987. 506 indexed citations breakdown →
13.
Vasquez, A. Cecilia, Maryam Feili‐Hariri, Rusung Tan, & Penelope A. Morel. (2004). Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice. Clinical & Experimental Immunology. 135(2). 209–218. 52 indexed citations
14.
Mailliard, Robbie B., Young-Ik Son, Richard E. Redlinger, et al.. (2003). Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function. The Journal of Immunology. 171(5). 2366–2373. 292 indexed citations
15.
Feili‐Hariri, Maryam, Dewayne Falkner, & Penelope A. Morel. (2002). Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. European Journal of Immunology. 32(7). 2021–2021. 83 indexed citations
16.
Feili‐Hariri, Maryam & Penelope A. Morel. (2001). Phenotypic and Functional Characteristics of BM-Derived DC from NOD and Non-Diabetes-Prone Strains. Clinical Immunology. 98(1). 133–142. 66 indexed citations
17.
Morel, Penelope A. & Timothy B. Oriss. (1998). Crossregulation Between Th1 and Th2 Cells. Critical Reviews in Immunology. 18(4). 275–303. 154 indexed citations
18.
Morel, Penelope A.. (1998). Mathematical modeling of immunological reactions. Frontiers in bioscience. 3(4). d338–347. 16 indexed citations
19.
Burke, Meghan A., et al.. (1997). Modeling the Proliferative Response of T Cells to IL-2 and IL-4. Cellular Immunology. 178(1). 42–52. 27 indexed citations
20.
Morel, Penelope A., et al.. (1977). [Lupus erythematosus and hereditary lack of complement. Review of about one case of C2 deficit (author's transl)].. PubMed. 104(12). 831–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026